Immunotherapy against glioblastoma using backpack‐activated neutrophils
Abstract Immune checkpoint inhibitors (ICIs) represent new therapeutic candidates against glioblastoma multiforme (GBM); however, their efficacy is clinically limited due to both local and systemic immunosuppressive environments. Hence, therapeutic approaches that stimulate local and systemic immune...
Saved in:
| Main Authors: | Tatsuya Fukuta, Ninad Kumbhojkar, Supriya Prakash, Suyog Shaha, A. Da Silva‐Candal, Kyung Soo Park, Samir Mitragotri |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Bioengineering & Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/btm2.10712 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research progress of immune checkpoint inhibitors in the treatment of glioblastoma
by: JIA Xiaorong, et al.
Published: (2024-05-01) -
Immune-checkpoint inhibitors for glioblastoma: what have we learned?
by: Antonio Omuro
Published: (2022-08-01) -
Efficient Photosensitizer Delivery by Neutrophils for Targeted Photodynamic Therapy of Glioblastoma
by: Ruojian Wen, et al.
Published: (2025-02-01) -
Elevated Neutrophil‐to‐Lymphocyte Ratio Correlates With Liver Metastases and Poor Immunotherapy Response in Stage IV Melanoma
by: Yannick Foerster, et al.
Published: (2025-02-01) -
Metabolic checkpoints in glioblastomas: targets for new therapies and non-invasive detection
by: Wenhao Li, et al.
Published: (2024-11-01)